NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









DecisionRx

DecisionRx

Private
Dover, DelawareHealthcare & Life Scienceshttps://decisionrx.com/

Last Round

Debt

Jan 11, 2024

Total Funding Raised

$110M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

DecisionRx is a managed care company that has developed a medication management platform designed to manage risk, make safer prescription decisions, and improve medication adherence.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Precision Medicine, Vertical SaaS

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

Medication Therapy OptimizationMTOpharmacogenomicsPGxvalue-based careprecision medicineclinical pharmacist servicesshared savings modelhealthcare analyticsmedication risk managementPGx testingdrug-gene testingpolypharmacy management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DecisionRx Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DecisionRx Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
DebtJan 11, 2024

Key People

Founding team and executive leadership

Laura Breedlove

Chief Technology Officer

Executive Team

DecisionRx Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors grew 45% MoM, reaching 1.4K.

  • Feb 28, 2024

    Grew 33% QoQ, from 15 to 20 employees.

DecisionRx Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DecisionRx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DecisionRx's valuation, stock price, and market status.

Firmographic Details

HeadquartersDover, Delaware
Employee Range14
Year Founded2022
Last FundingJan 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.